264 related articles for article (PubMed ID: 24844976)
1. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
Hassanaly SI; Talajic JC; Harissi-Dagher M
Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
[TBL] [Abstract][Full Text] [Related]
2. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
3. Boston type 1 keratoprosthesis: the CHUM experience.
Robert MC; Harissi-Dagher M
Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
[TBL] [Abstract][Full Text] [Related]
4. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia.
Bakhtiari P; Chan C; Welder JD; de la Cruz J; Holland EJ; Djalilian AR
Am J Ophthalmol; 2012 May; 153(5):967-971.e2. PubMed ID: 22265154
[TBL] [Abstract][Full Text] [Related]
5. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
Akpek EK; Harissi-Dagher M; Petrarca R; Butrus SI; Pineda R; Aquavella JV; Dohlman CH
Am J Ophthalmol; 2007 Aug; 144(2):227-231. PubMed ID: 17543875
[TBL] [Abstract][Full Text] [Related]
7. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
8. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
[TBL] [Abstract][Full Text] [Related]
9. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
Kang JJ; de la Cruz J; Cortina MS
Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
[TBL] [Abstract][Full Text] [Related]
10. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
Shah KJ; Cheung AY; Holland EJ
Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
[TBL] [Abstract][Full Text] [Related]
11. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
12. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
[TBL] [Abstract][Full Text] [Related]
13. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
14. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
15. International results with the Boston type I keratoprosthesis.
Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
[TBL] [Abstract][Full Text] [Related]
16. Treatment of aniridia with Boston type I keratoprosthesis.
Rixen JJ; Cohen AW; Kitzmann AS; Wagoner MD; Goins KM
Cornea; 2013 Jul; 32(7):947-50. PubMed ID: 23449480
[TBL] [Abstract][Full Text] [Related]
17. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
18. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
19. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and management of patients with Boston type 1 keratoprosthesis explantation--the University of Montreal Hospital Center experience.
Wang Q; Harissi-Dagher M
Am J Ophthalmol; 2014 Dec; 158(6):1297-1304.e1. PubMed ID: 25174898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
